NDC 72137-113-01 - 1ST MEDXPATCH WITH LIDOCAINE 4%-RX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72137-113
- Requested NDC
- 72137-113-01
- Package NDCs from labels
- 72137-113-01, 72137-113-15
- Manufacturer
- 1ST MEDX LLC
- Effective date
- 2026-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 1ST MEDXPATCH WITH LIDOCAINE 4%-RX - 1ST MEDX LLC | 1ST MEDX LLC | 2026-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
| 1ST MEDXPATCH WITH LIDOCAINE 4%-RX - Direct Rx | Direct Rx | 2020-10-14 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2022-02-01 | 1ST MEDX (as PLD) - PATCH WITH LIDOCAINE 4%-RX (72137-113) - DELIST |
| 2022-02-01 | 1ST MEDX (as PLD) - PATCH WITH LIDOCAINE 4%-RX (72137-113) - DELIST |
| 2022-02-01 | 1ST MEDX (as PLD) - PATCH WITH LIDOCAINE 4%-RX (72137-113) |
| 2022-01-28 | 1ST MEDX (as PLD) - PATCH WITH LIDOCAINE 4%-RX (72137-113) - DELIST |
| 2022-01-28 | 1ST MEDX (as PLD) - PATCH WITH LIDOCAINE 4%-RX (72137-113) - DELIST |
| 2022-01-28 | 1ST MEDX (as PLD) - PATCH WITH LIDOCAINE 4%-RX (72137-113) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72137-113-01 | 1ST MEDXPATCHWITH LIDOCAINE 4%-RX | 1 in 1 PATCH | PATCH | 1 | 11 | |
| 72137-113-15 | 1ST MEDXPATCHWITH LIDOCAINE 4%-RX | 10 in 1 POUCH | PATCH | 10 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72137-113-01 | EA - Each | 72137-113 | 3df4bb61-25c6-4ac6-9b41-5591e4af92a9 | 1 | 2022-06-06 |
| 72137-113-15 | EA - Each | 72137-113 | 4a157ee1-ff39-4b0b-a228-1d67b113d3c9 | 1 | 2018-04-19 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sunbetter Daily Mineral Protection Broad Spectrum SPF 70 Sheer Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | SKINBETTER SCIENCE LLC | 5410e0ed-aed5-3279-e063-6294a90a0c3e | 2026-06-12 | Warnings | 15FIX9V2JP |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | BM Private Limited | 53fa21d9-1f80-2e69-e063-6394a90ab9f3 | 2026-06-11 | Warnings | 059QF0KO0R |
| it cosmetics Your Skin But Better CC Plus Natural Matte Color Correcting Pore Refining Full Coverage Skin Balancing Serum Broad Spectrum SPF 40 Sunscreen | ENSULIZOLE, OCTISALATE AND TITANIUM DIOXIDE | IT COSMETICS, LLC | f2990320-b61d-40b8-ba79-18d6b37e7f52 | 2026-06-11 | Warnings | 15FIX9V2JP |
| lidocaine | LIDOCAINE | REMEDYREPACK INC. | 2cc3d25d-cefd-448d-beec-ac602c2110fd | 2026-06-11 | Warnings, Adverse reactions | 98PI200987 |
| MG PLUS MENTHOL | MENTHOL | RENU LABORATORIES, LLC | 53737365-b985-3800-e063-6294a90a37f2 | 2026-06-11 | Warnings | L7T10EIP3A |
| ANIXIKE Numbing | LIDOCAINE4% NUMBING | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a47f1ed-d8cf-3b0b-e063-6394a90a932a | 2026-06-11 | Warnings | 98PI200987 |
| Knee Pain Relief Gel-Patch | LIDOCAINE AND MENTHOL | Guangzhou Liuquanmiao Import & Export Trade Co., Ltd. | 54071b61-6e69-03e3-e063-6394a90a42f0 | 2026-06-11 | Warnings | 98PI200987 L7T10EIP3A |
| ANIXIKE Numbing | LIDOCAINE4% NUMBING | Jiangxi Yudexi Pharmaceutical Co., LTD | 4d5b7c4c-feac-4eeb-e063-6294a90a5748 | 2026-06-11 | Warnings | 98PI200987 |
| tina davies IceJelly Hemorrhoidal | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | TINA DAVIES PROFESSIONAL LLC | 580559bf-d91f-4bb3-9c9b-b7e2cd0686fd | 2026-06-11 | Warnings | 98PI200987 |
| Equaline Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | United Natural Foods, Inc. dba UNFI | bf87824a-522d-46da-81b6-e30ea11a2235 | 2026-06-11 | Warnings | PDC6A3C0OX |
| Oudetas Lidocaine Cream | LIDOCAINE CREAM | Guangzhou Jingliang Cosmetics Co., Ltd. | 53f11395-f460-943f-e063-6294a90affef | 2026-06-10 | Warnings | 98PI200987 |
| Warm Patch Tong Gu Huo Luo Gao | PAIN PATCH | Sheng Chang Pharmaceutical Co, Ltd. Zhongli Factory | 6906c4a0-1557-45e3-b915-80e4dd652ee7 | 2026-06-10 | Warnings | L7T10EIP3A LAV5U5022Y |
| HALLS Honey | MENTHOL | Mondelez Global LLC | 837f5ded-8efb-402b-a1bc-b5c142755660 | 2026-06-09 | Warnings | L7T10EIP3A |
| LidoMedix | LIDOCAINE, MENTHOL, CAMPHOR | Absolute Therapeutics, LLC | 53d504ef-eea3-6a47-e063-6394a90a1f65 | 2026-06-09 | Warnings | 98PI200987 L7T10EIP3A |
| RE-NUTRIV AGE REVERSAL VITAL RADIANCE SERUM FOUNDATION SPF 20 | OCTINOXATE AND TITANIUM DIOXIDE | ESTEE LAUDER INC | 53d76b02-442e-7a5d-e063-6394a90ae1b3 | 2026-06-09 | Warnings | 15FIX9V2JP |
| FUTURIST HYDRATING COLLAGEN-PEPTIDE MAKEUP BROAD SPECTRUM SPF 20 | OCTINOXATE AND TITANIUM DIOXIDE | ESTEE LAUDER INC | 53d9d689-4a86-5b9c-e063-6394a90aef18 | 2026-06-09 | Warnings | 15FIX9V2JP |
| Lidocaine 4 Percent | LIDOCAINE | Preferred Pharmaceuticals Inc. | ce379d77-bba4-4f8c-a42c-27ce06aa38a5 | 2026-06-09 | Warnings | 98PI200987 |
| XIMONTH Fungi Free Bee Venom Nail Soothing Serum | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 53bab969-8407-6334-e063-6294a90aa5d1 | 2026-06-08 | Warnings | 059QF0KO0R |
| Terramed Just Think Comfort Hemorrhoidal Wipes | LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | Rida LLC | f6ad00e7-c7b8-40b8-80c2-6e6bf85098b3 | 2026-06-08 | Warnings | 98PI200987 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.